Skip to main content
Inotuzumab ozogamicin with bosutinib well tolerated in R/R CML-LBP and Ph+ALL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Inotuzumab ozogamicin with bosutinib well tolerated in R/R CML-LBP and Ph+ALL
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Myelogenous Leukemia
1
1
Acute Lymphoblastic Leukemia
0
0.61
Cancer
0
0.58
Leukemia
0
0.58
Toxicology
0
0.36
Acute Leukemia
0
0.35
Grant
0
0.29
Refractory
0
0.29
Residual Disease
0
0.29
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Public Health & Prevention
0
0.4
Emergency Medicine
0
0.36
Edit Tags